Discover and read the best of Twitter Threads about #cardiogenicshock
Most recents (8)
🧵 Thread: The Future of Assessing Systemic Microcirculation in Cardiogenic Shock (CS) 🩺🫀
1/ Hey Twitterverse! Today, I want to talk about an exciting topic in cardiology & ICU: the role of evaluating systemic microcirculation in CS. 🌡️🫀 #ICU #Cardiology #Microcirculation
1/ Hey Twitterverse! Today, I want to talk about an exciting topic in cardiology & ICU: the role of evaluating systemic microcirculation in CS. 🌡️🫀 #ICU #Cardiology #Microcirculation
2/ CS is a life-threatening condition in which the heart is unable to pump enough blood to meet the body's metabolic needs.
academic.oup.com/ehjacc/article…
academic.oup.com/ehjacc/article…
3/ Traditionally, assessment of the macrocirculation (e.g., BP, LVEF, CO) has been the focus, but new research suggests that assessment of the microcirculation is the next step.💡
💡New research from our group @ESC_Journals indicates that #MCS might improve outcomes in patients with #heartfailure related #cardiogenicshock Let me walk you through it!
Actually, #cardiogenicshock has, for many years, been seen as predominantly caused by #myocardialinfarction However, recent evidence suggests that non-ischemic causes match it in frequency and impact on outcomes ‼️
pubmed.ncbi.nlm.nih.gov/30879324/
onlinelibrary.wiley.com/doi/full/10.10…
pubmed.ncbi.nlm.nih.gov/30879324/
onlinelibrary.wiley.com/doi/full/10.10…
This is concerning 🧐, as most RCTs on use of #MCS in #cardiogenicshock focus on patients with #myocardialinfarction and exclude those with #heartfailure related #cardiogenicshock resulting in an overall low level of evidence for this patient population
pubmed.ncbi.nlm.nih.gov/34145680/
pubmed.ncbi.nlm.nih.gov/34145680/
🔥Review on optimal targets in #CardiogenicShock in @JACCJournals #Advances by @benhibbertMDPhD & team 👏
Clinical, biochemical & hemodynamic targets to guide therapy & escalation of therapy.
@Sadeer_AlKindi @baileyannRN #ACCEarlyCareer #ACCFIT
👉jacc.org/doi/10.1016/j.…
Clinical, biochemical & hemodynamic targets to guide therapy & escalation of therapy.
@Sadeer_AlKindi @baileyannRN #ACCEarlyCareer #ACCFIT
👉jacc.org/doi/10.1016/j.…
Current guidelines focus on the t/t of inciting event & restore end-organ perfusion; inotropes/pressors to target MAP ≥65 mm Hg.
🏷 Asses serial markers of systemic perfusion- lactate, ScVO2, UOP, Cr, LFTs, mentation, temp, and invasive hemodynamics & target accordingly
🏷 Asses serial markers of systemic perfusion- lactate, ScVO2, UOP, Cr, LFTs, mentation, temp, and invasive hemodynamics & target accordingly
🏷Difference in #SCAI classes A-B & C-E is presence of hypoperfusion- clinical signs like cool mottled skin, poor UOP, confusion, & biochemical abnormalities like ⬆️ lactate, renal insufficiency, and ⬆️ LFTs.
🏷 RAP, ⬆️ shock stage over time, and late deterioration ⬆️ mortality
🏷 RAP, ⬆️ shock stage over time, and late deterioration ⬆️ mortality
Don’t miss a new accredited #tweetorial launching Monday here on @cardiomet_CE. Our newest core faculty member, #interventionalist & #SoMe education enthusiast @aayshacader will be discussing #antiplatelet tx in an oh-so-tough scenario--#cardiogenicshock complicating #STEMI.
FOLLOW US now and be there! @DLBHATTMD @DrMauricioCohen @SVRaoMD @HeartBobH @HeartOTXHeartMD @Heart_SCCT @TCTMD @GreggWStone @gabrielsteg @cpcannon @agtruesdell @evandrofilhobr @SCAI @SripalBangalore @mmamas1973 @SABOURETCardio @PCRonline @Pooh_Velagapudi #CardioTwitter
1) Welcome to a tweetorial on antiplatelet therapy for #STEMI in #cardiogenic shock #CS! Accredited for 0.50 credits by @academiccme! I am @aayshacader. Be sure to see prior tweetorials on this topic and still earn credit at cardiometabolic-ce.com/category/plate…
On this day, 20 years ago #September11 , I was attending the CVICU Service @BSWHTemple_IMED .
It was a very busy service and I was pre-rounding.
While listening to a patient’s chest, she gasped.
I took my stethoscope out of my ears and looked at a face of a woman in shock🧵
It was a very busy service and I was pre-rounding.
While listening to a patient’s chest, she gasped.
I took my stethoscope out of my ears and looked at a face of a woman in shock🧵
…not #CardiogenicShock , but this shock.
I sat on her bed and we watched together…in shock
I don’t know how many more minutes it was, but I eventually turned back to her.
She hugged me harder than I’ve ever been hugged before or since.
We cried a few tears 2/
I sat on her bed and we watched together…in shock
I don’t know how many more minutes it was, but I eventually turned back to her.
She hugged me harder than I’ve ever been hugged before or since.
We cried a few tears 2/
I told her that she was going to be alright…that WE were going to be alright & pat her on the shoulder as I resumed my exam.
As I turned to leave the room, the other plane hit. I looked at her & asked her if she was okay we me leaving. She said, “Yes, you have work to do” 3/
As I turned to leave the room, the other plane hit. I looked at her & asked her if she was okay we me leaving. She said, “Yes, you have work to do” 3/
1. Hot off the press - #EHJACVC Issue 1/2021 tweetorial 🔽
The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/article…
#ACVC_ESC #cardiotwitter
The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/article…
#ACVC_ESC #cardiotwitter
2. Issue focus: #CardiogenicShock (CS) management.
In the new "Sciencepulse", chaired by @ingo_ahrens, David Morrow from @BrighamWomens and @thiele_holger discuss differences and commonalities in CS management in Europe and North America academic.oup.com/ehjacc/article…
In the new "Sciencepulse", chaired by @ingo_ahrens, David Morrow from @BrighamWomens and @thiele_holger discuss differences and commonalities in CS management in Europe and North America academic.oup.com/ehjacc/article…
3. In an editorial titled "Potential growth in cardiogenic shock research though an international registry collaboration", @seanvandiepen and Dave Morrow call for a Hub-of-Spokes model in #CardiogenicShock research academic.oup.com/ehjacc/article…
#EHJACVC #CardioEd
#EHJACVC #CardioEd
Don’t forget the RV: by #DrJamesGoldstein...
Have you registered for the upcoming CSRC meeting? Join me & others from academia, industry, & regulatory agencies for a follow-up #CardiogenicShock Think Tank on July 24! Register here: bit.ly/2PtxKoE @CardiacSafety
For my part, I'll be talking about the possibility of Randomized, Embedded, Multifactorial, Adaptive, Platform trials and whether they could be a useful tool in generating evidence for the treatment of cardiogenic shock.
This is especially timely in light of the news that the critical care world has just launched the first #REMAP trial in the US:
